NASDAQ
Neurocrine Biosciences, Inc. (NBIX) has a free cash flow growth of -65.02% as of Friday, May 29, 2026. This represents a 223.71% decrease compared to its 12-month average of 52.56%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.